NewAmsterdam Pharma Company N.V. Warrant Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

NewAmsterdam Pharma Company N.V. Warrant Share Price Chart

$0.00$0.00

NewAmsterdam Pharma Company N.V. Warrant Stock Fundamentals & Key Indicators

Market Cap N/A	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) $-1.72	Revenue (TTM) $22.50M	Return On Equity (TTM) -29.82%
Profit Margin -905.74%	Debt to Equity 0.13	Quarterly Earnings Growth YoY N/A

NewAmsterdam Pharma Company N.V. Warrant Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025
Revenue	$1.40M	$2.28M	$29.11M	$2.98M	$19.14M	$348000.00
Net Profit	-$93.77M	-$39.01M	N/A	-$39.53M	-$17.36M	-$72.00M
Net Profit Margin	-6692.86%	-1711.58%	N/A	-1327.30%	-90.70%	-20691.09%
Income Change	N/A	58.40%	N/A	N/A	56.07%	-314.68%

NewAmsterdam Pharma Company N.V. Warrant Annual Profit & Loss

All figures in USD

Particulars	2023	2024	2025
Revenue	$14.09M	$45.56M	$22.50M
Net Profit	-$176.94M	-$241.60M	-$203.82M
Net Profit Margin	-1255.76%	-530.25%	-905.74%
Income Change	N/A	-36.54%	15.64%

About NewAmsterdam Pharma Company N.V. Warrant

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

NewAmsterdam Pharma Company N.V. Warrant Historical Returns

Month	Open	Close	Change %

NAMSW Share Price FAQs

What is NewAmsterdam Pharma Company N.V. Warrant share price today?

NewAmsterdam Pharma Company N.V. Warrant share price today is $0.00 as on August 10, 2026 at 10:41 am IST.

What is the 52 week high and 52 week low of NewAmsterdam Pharma Company N.V. Warrant stock?

52 week high/low data for NewAmsterdam Pharma Company N.V. Warrant is currently unavailable.

What is NAMSW's net income for the last quarter?

NAMSW's net income for the last quarter is -0.07B USD.

Can I buy NAMSW shares in India?

Yes. You can buy NAMSW in India by opening an international trading account.